Literature DB >> 29397153

Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on.

Todd K Rosengart1, Vivek Patel2, Frank W Sellke3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29397153      PMCID： PMC5860963          DOI： 10.1016/j.jtcvs.2017.11.104

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  23 in total

1.  Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.

Authors:  Elisa Yaniz-Galende; Maguelonne Roux; Sophie Nadaud; Nathalie Mougenot; Marion Bouvet; Olivier Claude; Guillaume Lebreton; Catherine Blanc; Florence Pinet; Fabrice Atassi; Claire Perret; France Dierick; Sébastien Dussaud; Pascal Leprince; David-Alexandre Trégouët; Giovanna Marazzi; David Sassoon; Jean-Sébastien Hulot
Journal:  J Am Coll Cardiol       Date:  2017-08-08       Impact factor: 24.094

2.  "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors.

Authors:  Megumi Mathison; Vivek P Singh; Robert P Gersch; Maricela O Ramirez; Austin Cooney; Stephen M Kaminsky; Maria J Chiuchiolo; Ahmed Nasser; Jianchang Yang; Ronald G Crystal; Todd K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-27       Impact factor: 5.209

3.  Cardiac Cell Therapies for the Treatment of Acute Myocardial Infarction: A Meta-Analysis from Mouse Studies.

Authors:  Cajetan Immanuel Lang; Markus Wolfien; Anne Langenbach; Paula Müller; Olaf Wolkenhauer; Arash Yavari; Hüseyin Ince; Gustav Steinhoff; Bernd Joachim Krause; Robert David; Änne Glass
Journal:  Cell Physiol Biochem       Date:  2017-05-25

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 5.  Stem-cell therapy for cardiac disease.

Authors:  Vincent F M Segers; Richard T Lee
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

Review 6.  Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

Authors:  Pratik A Lalit; Derek J Hei; Amish N Raval; Timothy J Kamp
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

Review 7.  Stem cell treatment for acute myocardial infarction.

Authors:  Sheila A Fisher; Huajun Zhang; Carolyn Doree; Anthony Mathur; Enca Martin-Rendon
Journal:  Cochrane Database Syst Rev       Date:  2015-09-30

Review 8.  Direct cellular reprogramming for cardiac repair and regeneration.

Authors:  Jonathan A Batty; Jose A C Lima; Vijay Kunadian
Journal:  Eur J Heart Fail       Date:  2015-12-03       Impact factor: 15.534

Review 9.  Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.

Authors:  Ming Hao; Richard Wang; Wen Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2017-01-17       Impact factor: 2.916

10.  In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.

Authors:  Megumi Mathison; Robert P Gersch; Ahmed Nasser; Sarit Lilo; Mallory Korman; Mitchell Fourman; Neil Hackett; Kenneth Shroyer; Jianchang Yang; Yupo Ma; Ronald G Crystal; Todd K Rosengart
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501
View more
  2 in total

Review 1.  What's in a cardiomyocyte - And how do we make one through reprogramming?

Authors:  Benjamin Keepers; Jiandong Liu; Li Qian
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-03-25       Impact factor: 4.739

2.  Clinical potential of angiogenic therapy and cellular reprogramming.

Authors:  Christopher T Ryan; Vivek Patel; Todd K Rosengart
Journal:  JTCVS Open       Date:  2021-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.